KR100330706B1 - 5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same - Google Patents

5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same Download PDF

Info

Publication number
KR100330706B1
KR100330706B1 KR1020000013303A KR20000013303A KR100330706B1 KR 100330706 B1 KR100330706 B1 KR 100330706B1 KR 1020000013303 A KR1020000013303 A KR 1020000013303A KR 20000013303 A KR20000013303 A KR 20000013303A KR 100330706 B1 KR100330706 B1 KR 100330706B1
Authority
KR
South Korea
Prior art keywords
medium
glucose
inosinic acid
strain
kfcc
Prior art date
Application number
KR1020000013303A
Other languages
Korean (ko)
Other versions
KR20010089946A (en
Inventor
김정환
정성오
이진호
강성구
황수연
김현수
이재철
이병춘
이재흥
Original Assignee
손 경 식
제일제당주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 손 경 식, 제일제당주식회사 filed Critical 손 경 식
Priority to KR1020000013303A priority Critical patent/KR100330706B1/en
Publication of KR20010089946A publication Critical patent/KR20010089946A/en
Application granted granted Critical
Publication of KR100330706B1 publication Critical patent/KR100330706B1/en

Links

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04DNON-POSITIVE-DISPLACEMENT PUMPS
    • F04D25/00Pumping installations or systems
    • F04D25/02Units comprising pumps and their driving means
    • F04D25/08Units comprising pumps and their driving means the working fluid being air, e.g. for ventilation

Abstract

본 발명은 포도당을 자화하여 5'-이노신산을 생산하는 코리네박테리움 암모니아게네스(Corynebacterium ammoniagenes) MP377(KFCC-11141)에 관한 것으로서, 탄소원으로서 포도당만을 사용하여 배양액내에 5'-이노신산을 고농도로 축적할 수 있으므로, 보다 경제적인 방법으로 5'-이노신산을 고농도·고수율로 제조할 수 있다.The present invention relates to Corynebacterium ammoniagenes MP377 (KFCC-11141), which magnetizes glucose to produce 5'-inosinic acid. The present invention relates to a high concentration of 5'-inosinic acid in a culture medium using only glucose as a carbon source. Since it can accumulate, 5'-inosinic acid can be manufactured with high concentration and high yield by a more economical method.

Description

5'-이노신산을 생산하는 미생물 및 그를 이용한 5'-이노신산의 제조방법{5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same}5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same}

본 발명은 5'-이노신산(5'-inosinic acid)을 생산하는 미생물에 관한 것으로서, 보다 상세하게는, 배양액중에 5'-이노신산을 고농도로 축적시키는, 코리네박테리움(종전의 브레비박테리움(Brevibacterium)) 암모니아게네스(Corynebacterium ammoniagenes) ATCC 6872의 변이주 KFCC-10814(대한민국특허 제 127853 호)로부터 유래된 변이주 MP377(KFCC-11141)에 관한 것이다.The present invention relates to a microorganism producing 5'-inosinic acid, and more particularly, Corynebacterium (formerly Brevibacterium), which accumulates high concentration of 5'-inosinic acid in a culture solution. ( Brevibacterium )) Variant strain MP377 (KFCC-11141) derived from variant strain KFCC-10814 (Korean Patent No. 127853) of Corynebacterium ammoniagenes ATCC 6872.

5'-이노신산은 핵산 생합성 대사계의 중간 물질로서 동식물의 체내에서 생리적으로 중요한 의미를 가질뿐 아니라 식품, 의약품 등 다방면에서 이용되고 있으며, 특히 음식물의 조미료로서 글루탐산 나트륨과 더불어 소량 사용하면 맛의 상승 효과가 커지는 등 정미성 조미료로 각광받고 있는 핵산계 조미료 중의 하나이다. 5'-inosinic acid is an intermediate in nucleic acid biosynthetic metabolic system and has a physiological significance in animals and plants. It is used in many fields such as food and medicine. Especially, when used in small amounts together with sodium glutamate as a seasoning for food, the taste is increased. It is one of nucleic acid-based seasonings that has been in the spotlight as a savory seasoning, such as increase in effect.

종래 코리네박테리움 암모니아게네스 ATCC 6872의 변이주인 KFCC-10814는 포도당과 과당의 1:1 혼합당을 이용하여 발효시킬 경우 고농도의 5'-이노신산을 생산한다. 그러나, 탄소원으로서 포도당만을 사용할 경우 이 변이주의 5'-이노신산 생산능은 현저히 저하된다. 일반적으로 탄소원으로서 발효에 사용하는 포도당의 가격이 원당을 가수분해하여 얻는 포도당과 과당의 1:1 혼합당에 비하여 저렴하므로 더욱 경제적인 생산을 위해서는 포도당만을 탄소원으로 하여 5'-이노신산을 고농도로 생산하는 미생물을 개발할 필요가 있다. 이와 같은 미생물을 획득하는 방법에는 여러 가지가 있을 수 있으며, 그중 하나의 방법으로 이미 획득된 포도당과 과당의 1:1 혼합당을 이용하여 5'-이노신산을 고농도로 생산하는 변이주로부터 포도당만을 이용하여 5'-이노신산을 고농도로 생산하는 신규의 변이주를 제조하는 방법이 있다.KFCC-10814, a variation of the conventional Corynebacterium ammonia genes ATCC 6872, produces high concentrations of 5'-inosinic acid when fermented using a 1: 1 mixed sugar of glucose and fructose. However, when only glucose is used as the carbon source, the 5'-inosinic acid production capacity of the mutant strain is significantly reduced. In general, the price of glucose used for fermentation as a carbon source is cheaper than the 1: 1 mixed sugar of glucose and fructose obtained by hydrolyzing the raw sugar. Therefore, for more economical production, 5'-inosinic acid is produced in high concentration using only glucose as a carbon source. There is a need to develop microorganisms. There are a number of methods for obtaining such microorganisms, and one of them is using only glucose from a mutant strain that produces a high concentration of 5'-inosinic acid using a 1: 1 mixed sugar of glucose and fructose already obtained by using one of them. There is a method for producing novel mutants that produce high concentrations of 5'-inosinic acid.

따라서, 본 발명의 목적은 탄소원으로서 포도당과 과당을 혼합하여 배양하면 5'-이노신산을 고농도로 생산하지만, 포도당만을 사용하면 그 자화성이 현저히 떨어지고, 특히 5'-이노신산 생성능이 현격히 저하되는 코리네박테리움 암모니아게네스의 5'-이노신산 생산용 변이주 KFCC-10814에 대해 6-머캅토퓨린(6-mercaptopurine) 내성을 부여함으로써, 포도당을 자화하면서 5'-이노신산을 고농도로 생산하는 변이주 MP377(KFCC-11141), 및 그를 이용하여 5'-이노신산을 제조하는 방법을 제공하기 위한 것이다.Accordingly, an object of the present invention is to produce a high concentration of 5'-inosinic acid when cultured by mixing glucose and fructose as a carbon source, but the use of glucose alone, the magnetization is significantly reduced, especially the 5'-inosinic acid production ability is significantly reduced Mutant strain MP377 which produces high concentration of 5'-inosinic acid while magnetizing glucose by conferring 6-mercaptopurine resistance to the strain KFCC-10814 of bacterium ammonia genes KFCC-10814 -11141), and a method for producing 5'-inosinic acid using the same.

첫째, 본 발명은 포도당을 자화하여 5'-이노신산을 생산하는 코리네박테리움 암모니아게네스 MP377(KFCC-11141)에 관한 것이다. 본 발명의 미생물은 300㎍/㎖이상의 6-머캅토퓨린에 대해 내성을 갖는 것이다.First, the present invention relates to Corynebacterium ammonia genes MP377 (KFCC-11141), which magnetizes glucose to produce 5'-inosinic acid. The microorganism of the present invention is resistant to 6-mercaptopurine of 300 µg / ml or more.

둘째, 본 발명은 상기 미생물을 배양하여 그 배양물로부터 5'-이노신산을 제조하는 방법에 관한 것이다. 본 발명에 따른 방법에서는, 탄소원으로서 포도당을 사용하는 것이 바람직하다.Secondly, the present invention relates to a method of culturing the microorganism to produce 5'-inosinic acid from the culture. In the process according to the invention, preference is given to using glucose as the carbon source.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 균주 코리네박테리움 암모니아게네스 MP377은 종래의 코리네박테리움 암모니아게네스 ATCC 6872의 변이주로서, ⅰ) 5'-이노신산을 생산하는 아데닌(adenine) 누출형 변이주(leaky mutant)[Agric. Biol. Chem., Vol. 47, No. 5, p1035-1041, 1983 (KY13102, KY13171, KY13184 등)] 또는 아데닌과 크산틴(xanthine) 또는 구아닌(guanine) 동시 요구성 균주와는 달리, 아데닌을 요구하는 반면, 크산틴 또는 구아닌을 요구하지 않지만 이들을 첨가함으로써 생육이 촉진되며, ⅱ) 우레아(urea)를 자화할 수 있는 우레아제(urease)가 결손되고, ⅲ) 세포내에 생성된 대량의 5'-이노신산을 세포밖으로 잘 분비할 수 있도록 세포벽 합성능력이 부분적으로 결손된 것으로 여겨지는, 세포벽 분해효소인 라이소자임(lysozyme)에 대해 높은 감수성을 가지며, ⅳ) 배양과정에 탄소원으로서 포도당과 과당의 혼합당 또는 기타 당류 등을 고농도로 첨가하거나 배양 후반에 5'-이노신산이 배양액내에 고농도로 축적되면, 균체 외부의 삼투압이 증가하여 5'-이노신산 생산 세포의 정상적인 생리활성이 저해됨으로 인해, 균체성장이 둔화되고 5'-이노신산 생성이 저하되는 것을 방지할 수 있는 삼투압 내성 형질이 부여되어 있으며, ⅴ) 5'-이노신산 생합성에 있어서 퓨린계 염기들에 의한 조절을 해제하기위한 일환으로, 퓨린계 염기 유사체의 일종인 6-머캅토퓨린에 대한 내성 형질을 갖는다. 특히, 6-머캅토퓨린에 대한 내성 형질을 부여하여 탄소원으로 포도당만을 사용하는 것이 가능하게 되며, 질소원 제한 영양배지에서 호기적으로 배양하여 배양액중에 5'-이노신산을 고농도·고수율로 직접 축적시킨다. 상기 균주는 2000년 1월 29일자로 사단법인 한국종균협회에 기탁하여, 수탁번호 제 KFCC-11141 호를 부여받았다.The strain Corynebacterium ammonia genes MP377 of the present invention is a variant of the conventional Corynebacterium ammonia genes ATCC 6872, i) adenine (leaky mutant) that produces 5'-inosinic acid (leaky mutant) [ Agric . Biol. Chem. , Vol. 47, No. 5, p1035-1041, 1983 (KY13102, KY13171, KY13184, etc.) or, unlike adenine and xanthine or guanine co-required strains, require adenine, while not requiring xanthine or guanine However, by adding them, growth is promoted, ii) urease capable of magnetizing urea is depleted, and iii) cell wall synthesis to secrete large amounts of 5'-inosinic acid produced in cells well outside the cell. It has a high sensitivity to lysozyme, a cell wall degrading enzyme that is considered to be partially deficient, and i) adds a high concentration of glucose and fructose or other sugars as a carbon source to the culture process, When 5'-inosinic acid accumulates at a high concentration in the culture medium, the osmotic pressure outside the cells increases, thereby inhibiting normal physiological activity of 5'-inosinic acid producing cells. The osmolality resistant trait is provided to prevent the slowing and lowering of 5'-inosinic acid production. I) Purine base as part of releasing the control by purine bases in 5'-inosine acid biosynthesis. It has a resistance trait to 6-mercaptopurine, which is a kind of analog. In particular, it is possible to use only glucose as a carbon source by imparting resistance to 6-mercaptopurine, and by aerobic culture in a nitrogen source-limited nutrient medium, 5'-inosinic acid is directly accumulated in high concentration and high yield. . The strain was deposited on January 29, 2000 with the Korean spawn association, which was granted accession number KFCC-11141.

본 발명에 따른 균주를 제조하는 방법을 보다 구체적으로 설명하면 하기와 같다.Referring to the method for producing a strain according to the invention in more detail as follows.

먼저 코리네박테리움 암모니아게네스 ATCC 6872를 친주로 하여 X-선, 자외선 조사 등에 의해 5'-이노신산 생성능을 갖고 생육을 위해 아데닌을 요구하며 아데닌, 구아닌 첨가 최소배지(주 4)에서 생육이 촉진되는 CS101를 얻는다. 이때, 변이주 분리배지로 영양배지(주 1), 최소배지(주 2), 최소첨가배지(주 3, 4)를 사용하여 변이주를 분리한다. 다음으로, CS101을 친주로 하여 X-선, 자외선 또는 N-메틸-N-니트로-N-니트로소구아닌, 디에틸설파이드, 에틸아민 등 화학적 돌연변이원으로 처리한후 배지(주 1)에 도말하여 콜로니(colony)를 순수 분리한다. 그후 라이소자임이 농도별로 첨가된 배지(주 5)를 사용하여 CS101 보다 높은 라이소자임 감수성을 갖는 CS1019를 선별한다. 그 다음으로, 변이주 CS1019를 상기한 유기 변이제로 처리한후 배지(주 1)에서 순수 분리하고 크리스텐센우레아 검사배지, 배지(주 7)에서 우레아제가 결손된 변이주 CS10197을 선별한다. 변이주 CS10197을 다시 동일한 방법을 사용하여 3,4-디하이드로프롤린(3,4-dehydro-DL-proline)이 농도별로첨가된 배지(주 6)를 사용하여 CS10197 보다 높은 3,4-디하이드로프롤린 내성을 갖는 변이주 CS101975를 얻는다. 이때, 대부분의 변이주들은 3,4-디하이드로프롤린의 농도가 높아 성장할 수 없으며 삼투압 내성이 높은 변이주는 성장가능하므로 3,4-디하이드로프롤린의 농도를 단계적으로 높여 3500㎍/㎖에서도 성장가능한 변이주를 얻는다. 여기에서 얻은 변이주를 원심분리하여 3,4-디하이드로프롤린이 3500㎍/㎖의 농도로 함유된 배지(주 6)에 도말하여 생성된 콜로니를 순수 분리하여 KFCC-10814를 얻는다.First of all, Corynebacterium ammonia genes ATCC 6872 is a parent strain, and it has the ability to produce 5'-inosinic acid by X-ray, ultraviolet irradiation, etc., and requires adenine for growth, and it promotes growth in the minimum medium containing adenine and guanine (Note 4). Get CS101. At this time, mutant strains are separated using a nutrient medium (Note 1), a minimum medium (Note 2), and a minimum addition medium (Notes 3 and 4) as the mutant strain separation medium. Next, CS101 was used as a parent strain, and treated with chemical mutagen such as X-ray, ultraviolet ray or N-methyl-N-nitro-N-nitrosoguanine, diethylsulfide, ethylamine, and then plated on the medium (Note 1). Colony is purely separated. CS1019 having higher lysozyme susceptibility than CS101 is then selected using medium supplemented with lysozyme by concentration. Next, after mutant CS1019 was treated with the above-described organic mutants, pure strain was isolated from the medium (Note 1), and mutant CS10197 lacking urease was selected from the Christensenurea test medium and the medium (Note 7). Variant CS10197 was again used in the same manner using 3,4-dihydroproline higher than CS10197 using 3,4-dehydro-DL-proline-concentrated medium (Note 6). Mutant strain CS101975 with resistance is obtained. At this time, most of the mutants can not grow because the concentration of 3,4-dihydroproline is high, and the strains with high osmotic resistance can be grown, so the mutants that can be grown at 3500㎍ / ㎖ by gradually increasing the concentration of 3,4-dihydroproline Get The mutant strains thus obtained were centrifuged to plate 3,4-dihydroproline in a medium (Note 6) containing 3500 µg / ml to purely separate the resulting colonies to obtain KFCC-10814.

본 발명에서는, 상기 변이주 KFCC-10814를 다시 동일한 방법을 사용하여 6-머캅토퓨린을 농도별로 첨가한 배지(주 8)를 사용하여 KFCC-10814 보다 높은 6-머캅토퓨린 내성을 갖는 변이주 CSJ6을 얻는다. 이때, 대부분의 변이주들은 6-머캅토퓨린의 농도가 높아 성장할 수 없으며, 6-머캅토퓨린이 300㎍/㎖의 농도로 함유된 배지(주 8)에 도말하여 생성된 콜로니를 순수 분리하여 MP377라 명명하였다.In the present invention, the mutant strain CSJ6 having higher 6-mercaptopurine resistance than KFCC-10814 was prepared using the medium (Note 8) in which the mutant strain KFCC-10814 was added to the 6-mercaptopurine concentration by using the same method again. Get At this time, most of the mutants were not able to grow due to the high concentration of 6-mercaptopurine, MP377 by pure separation of colonies produced by smearing the medium (Note 8) containing 6-mercaptopurine at a concentration of 300 ㎍ / ㎖ It was named.

(주 1) 영양배지; 펩톤 1%, 육즙 1%, 염화나트륨 0.25%, 효모엑기스 1%, 한천 2%, pH 7.2(Note 1) nutrient medium; 1% peptone, 1% gravy, 0.25% sodium chloride, 1% yeast extract, 2% agar, pH 7.2

(주 2) 최소배지; 포도당 2%, 황산나트륨 0.3%, 인산제1칼륨 0.1%, 인산제2칼륨 0.3%, 황산마그네슘 0.3%, 염화칼슘 10mg/ℓ, 황산철 10mg/ℓ, 황산아연 1mg/ℓ, 황산망간 1mg/ℓ, L-시스테인 20mg/ℓ, 칼슘판토테네이트 10mg/ℓ, 티아민염산염 5mg/ℓ, 바이오틴 30㎍/ℓ, 요소 0.2%, pH 7.3(Note 2) Minimum Medium; Glucose 2%, Sodium sulfate 0.3%, Potassium phosphate 0.1%, Dipotassium phosphate 0.3%, Magnesium sulfate 0.3%, Calcium chloride 10mg / L, Iron sulfate 10mg / L, Zinc sulfate 1mg / L, Manganese sulfate 1mg / L, L-cysteine 20mg / l, calcium pantothenate 10mg / l, thiamine hydrochloride 5mg / l, biotin 30µg / l, urea 0.2%, pH 7.3

(주 3) 아데닌 최소첨가배지; (주 2) 배지에 아데닌을 10∼500mg/ℓ까지 농도별로 첨가한 배지.(Note 3) adenine minimal addition medium; (Note 2) A medium in which adenine was added in a concentration range of 10 to 500 mg / l.

(주 4) 아데닌, 구아닌 최소첨가배지; 최소배지에 아데닌, 구아닌(또는 크산틴을 각각 10∼500mg/ℓ까지 농도별로 첨가한 배지.(Note 4) adenine, guanine minimal addition medium; Medium in which adenine and guanine (or xanthine are added at a concentration of 10 to 500 mg / l, respectively) in a minimum medium.

(주 5) 라이소자임 첨가배지; (주 1) 배지에서 라이소자임 1∼100㎍/ℓ까지 농도별로 첨가한 배지.(Note 5) lysozyme addition medium; (Note 1) A medium added by concentration up to 1 to 100 µg / L in lysozyme in the medium.

(주 6) 3,4-디하이드로프롤린 첨가배지; (주 1) 배지에서 3,4-디하이드로프롤린 100∼5000㎍/ℓ까지 농도별로 첨가한 배지.(Note 6) 3,4-dihydroproline addition medium; (Note 1) A medium added by concentration up to 100 to 5000 µg / L in 3,4-dihydroproline in the medium.

(주 7) 크리스텐센우레아 검사배지; 펩톤 1.0g ,포도당 1.0g, 염화나트륨 5.0g, 인산제1칼륨 2.0g, 페놀레드 0.012g, 한천 20g, 요소 20g, 증류수 1ℓ(7) Christensenurea test medium; 1.0 g of peptone, 1.0 g of glucose, 5.0 g of sodium chloride, 2.0 g of potassium phosphate, 0.012 g of phenol red, 20 g of agar, 20 g of urea, 1 l of distilled water

(주 8) 6-머캅토퓨린 첨가배지; (주 1) 배지에서 6-머캅토퓨린 300㎍/㎖를 첨가한 배지.(Note 8) 6-mercaptopurine addition medium; (Note 1) A medium to which 300 µg / ml of 6-mercaptopurine was added.

본 발명에서 분리하여 획득한 신규 변이주 MP377의 생화학적 특성은 하기 표 1, 표 2 및 표 3에 기재된 바와 같다.Biochemical properties of the novel mutant strain MP377 obtained separately in the present invention are as described in Table 1, Table 2 and Table 3.

특성characteristic ATCC 6872(친주)ATCC 6872 (parent) KFCC-10617KFCC-10617 KFCC-10814KFCC-10814 MP377(KFCC-11141)MP377 (KFCC-11141) 아데닌Adenine 비요구성Composition 요구성Demand 요구성Demand 요구성Demand 구아닌(크산틴)Guanine (Xanthine) 비요구성Composition 누출형Leak type 누출형Leak type 누출형Leak type 비오틴Biotin 요구성Demand 요구성Demand 요구성Demand 요구성Demand 라이소자임(최저억제농도)Lysozyme (lowest inhibitory concentration) 80㎍/㎖80 µg / ml 15㎍/㎖15 µg / ml 8㎍/㎖8 µg / ml 8㎍/㎖8 µg / ml 3,4디하이드로프로린내성3,4 dihydroproline resistance 1000㎍/㎖1000 µg / ml 2000㎍/㎖2000 µg / ml 3500㎍/㎖3500 µg / ml 3500㎍/㎖3500 µg / ml 6-머캅토퓨린 내성6-mercaptopurine resistance 20㎍/㎖20 µg / ml 50㎍/㎖50 µg / ml 100㎍/㎖100 µg / ml 300㎍/㎖300 µg / ml

시험 균주명Test strain name 검사배지 색깔Badge color 우레아제Urease ATCC 6872(친주,우레아제 보유균주)ATCC 6872 (Protein stock, urease strain) 적 색Red ++ E.coli(우레아제가 결여된 표준균주) E. coli (standard strain lacking urease) 황 색yellow -- KFCC-10814KFCC-10814 황 색yellow -- MP377(KFCC-11141)MP377 (KFCC-11141) 황 색yellow --

세포내 프폴린(L-proline) 농도Intracellular L-proline Concentration 균 주Strain 농 도Concentration ATCC 6872(친주) ATCC 6872 (parent) -- KFCC-10617(종래 균주)KFCC-10617 (conventional strain) 0.910.91 KFCC-10814KFCC-10814 1.771.77 MP377(KFCC-11141)MP377 (KFCC-11141) 1.831.83

상기한 바와 같이, 본 발명의 균주 MP377은 발효 배양액중에 직접 5'-이노신산을 축적시키고 5'-이노신산 생산능력을 갖는 아데닌 요구성, 구아닌 누출형 변이주로서, 세포벽 외부로의 특정 대사산물의 분비기능이 증가된, 라이소자임에 대한 높은 감수성을 갖고, 배양과정중 고농도의 탄소원이 배양액에 존재하거나 5'-이노신산이 많이 생성될 경우, 균체 외부의 고농도 용질에 의해 생성된 삼투압에 의한 정상적인 생리 활성 저해현상을 방지하기 위해, 균체 내부에 특정 용질인 프롤린(L-proline)의 농도가 증대되어 삼투압에 의한 영향을 배제할 수 있는, 3,4-디하이드로프롤린에 대해 높은 내성을 가지며, 6-머캅토퓨린 내성을 가짐과 동시에 포도당 자화를 통한 5'-이노신산 생성능이 증대된 특성을 갖는 변이주이다.As described above, strain MP377 of the present invention is an adenine-required, guanine-leak type mutant having 5'-inosine acid and 5'-inosine acid production capacity directly in fermentation broth, and secreting a specific metabolite out of the cell wall. This increased sensitivity to lysozyme, and when a high concentration of carbon source is present in the culture medium or a large amount of 5'-inosinic acid is produced during the culture process, normal physiological activity inhibition by the osmotic pressure generated by the high concentration solute outside the cells To prevent this, 6-mercapto has a high resistance to 3,4-dihydroproline, which can increase the concentration of a specific solute proline (L-proline) inside the cell to exclude the effects of osmotic pressure It is a mutant strain that has the characteristics of purin resistance and increased ability to produce 5'-inosinic acid through glucose magnetization.

5'-이노신산은 하기 실시예에 기재된 바와 같이 온도 25∼35℃, pH 6.0∼8.0으로 유지하면서 3∼4일간 5ℓ 발효조에서 호기적으로 배양하여 축적된 5'-이노신산을 상법에 따라 분리정제하여 수득한다.5'-inosinic acid was separated and purified according to the conventional method by accumulating 5'-inosinic acid accumulated in aerobic culture in a 5 L fermenter for 3 to 4 days while maintaining the temperature at 25 to 35 ° C and pH 6.0 to 8.0 as described in the following Examples. To obtain.

[실시예]EXAMPLE

이하, 본 발명을 실시예를 통하여 보다 구체적으로 설명하나, 이는 본 발명의 이해를 돕기위한 것일뿐, 본 발명의 범위가 이에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, which are only intended to help understanding of the present invention, but the scope of the present invention is not limited thereto.

실시예 1Example 1

사용 균주: MP377(KFCC-11141)Use strain: MP377 (KFCC-11141)

종배지: 포도당 5%, 펩톤 0.5%, 육즙 0.5%, 효모엑기스 1%, 염화나트륨 0.25%, 아데닌 100mg/ℓ, 구아닌 100mg/ℓ, pH 7.6Species medium: glucose 5%, peptone 0.5%, broth 0.5%, yeast extract 1%, sodium chloride 0.25%, adenine 100 mg / l, guanine 100 mg / l, pH 7.6

발효배지: 인산제1칼륨 1.5%, 인산제2칼륨 2.5%, 염화암모늄 1%, 황산마그네슘 1%, 염화칼슘 0.01%, 황산철 10mg/ℓ, 황산망간 10mg/ℓ, 황산아연 10mg/ℓ, 옥수수침지여액 20%, 바이오틴 30㎍/ℓ, 티아민염산 5mg/ℓ, 아데닌 100mg/ℓ, 구아닌 100mg/ℓ, 포도당 및 당밀을 혼합하여 환원당으로 6%(포도당 5.6%, 당밀 0.4%)되게 첨가하여 사용하였다.Fermentation medium: 1.5% potassium phosphate, 2.5% potassium diphosphate, 1% ammonium chloride, 1% magnesium sulfate, 0.01% calcium chloride, 10mg / l iron sulfate, 10mg / l manganese sulfate, 10mg / l zinc sulfate, corn 20% dipping filtrate, biotin 30㎍ / ℓ, thiamine hydrochloride 5mg / ℓ, adenine 100mg / ℓ, guanine 100mg / ℓ, glucose and molasses are mixed and added to reducing sugar 6% (glucose 5.6%, molasses 0.4%) It was.

발효방법: 상기 종배지 3㎖를 지름 18mm 시험관에 분주하고 상법에 따라 가압 살균한후 사용 균주를 접종하고 30℃에서 24시간 진탕배양하여 종배양액으로 사용하였다. 발효배지 40㎖를 500㎖ 진탕용 삼각플라스크에 분주하고 120℃에서 10분간 가압 살균하여 종배양액 3㎖를 식균한후 5일간 배양하였다. 회전수는 분당 200회, 온도 30℃, pH 7.0으로 조절하였다. 배지내 5'-이노신산의 축적량은 17.6g/ℓ이었다.Fermentation method: 3 ml of the seed medium was dispensed into a 18 mm diameter test tube, autoclaved and sterilized according to a conventional method, followed by inoculation of the strain used, followed by shaking culture at 30 ° C. for 24 hours. 40 ml of the fermentation broth was dispensed into a 500 ml shake flask, and sterilized under pressure at 120 ° C. for 10 minutes to incubate 3 ml of the culture medium and incubated for 5 days. Rotation speed was adjusted to 200 times per minute, temperature 30 ℃, pH 7.0. The accumulation amount of 5'-inosinic acid in the medium was 17.6 g / l.

실시예 2Example 2

사용 균주: MP377(KFCC-11141)Use strain: MP377 (KFCC-11141)

종배지: 포도당 5%, 펩톤 0.5%, 육즙 0.5%, 효모엑기스 1%, 염화나트륨 0.25%, 아데닌 100mg/ℓ, 구아닌 100mg/ℓ, pH 7.6Species medium: glucose 5%, peptone 0.5%, broth 0.5%, yeast extract 1%, sodium chloride 0.25%, adenine 100 mg / l, guanine 100 mg / l, pH 7.6

발효배지: 인산제1칼륨 1.5%, 인산제2칼륨 2.5%, 염화암모늄 1%, 황산마그네슘 1%, 염화칼슘 0.01%, 황산철 10mg/ℓ, 황산망간 10mg/ℓ, 황산아연 10mg/ℓ, 옥수수침지여액 20%, 바이오틴 30㎍/ℓ, 티아민염산 5mg/ℓ, 아데닌 100mg/ℓ, 구아닌 100mg/ℓ, 과당, 포도당 및 당밀을 혼합하여 환원당으로 6%(과당 2.8%, 포도당 2.8%, 당밀 0.4%)되게 첨가하여 사용하였다.Fermentation medium: 1.5% potassium phosphate, 2.5% potassium diphosphate, 1% ammonium chloride, 1% magnesium sulfate, 0.01% calcium chloride, 10mg / l iron sulfate, 10mg / l manganese sulfate, 10mg / l zinc sulfate, corn Dipping Filtrate 20%, Biotin 30㎍ / ℓ, Thiamine Hydrochloride 5mg / ℓ, Adenine 100mg / ℓ, Guanine 100mg / ℓ, Fructose, Glucose and Molasses are mixed, 6% as reducing sugar (Fructose 2.8%, Glucose 2.8%, Molasses 0.4 %) Was used.

발효방법: 상기 종배지 3㎖를 지름 18mm 시험관에 분주하고 상법에 따라 가압 살균한후 사용 균주를 접종하고 30℃에서 24시간 진탕배양하여 종배양액으로 사용하였다. 발효배지 40㎖를 500㎖ 진탕용 삼각플라스크에 분주하고 120℃에서 10 분간 가압 살균하여 종배양액 3㎖를 식균한후 5일간 배양하였다. 회전수는 분당 200회, 온도 30℃, pH 7.0으로 조절하였다. 배지내 5'-이노신산의 축적량은 15.5g/ℓ이었다.Fermentation method: 3 ml of the seed medium was dispensed into a 18 mm diameter test tube, autoclaved and sterilized according to a conventional method, followed by inoculation of the strain used, followed by shaking culture at 30 ° C. for 24 hours. 40 ml of the fermentation broth was dispensed into a 500 ml shake flask, sterilized under pressure at 120 ° C. for 10 minutes, and 3 ml of the culture medium was incubated for 5 days. Rotation speed was adjusted to 200 times per minute, temperature 30 ℃, pH 7.0. The accumulation amount of 5'-inosinic acid in the medium was 15.5 g / l.

비교예 1Comparative Example 1

사용 균주: KFCC-10814Strain used: KFCC-10814

종배지: 포도당 5%, 펩톤 0.5%, 육즙 0.5%, 효모엑기스 1%, 염화나트륨 0.25%, 아데닌 100mg/ℓ, 구아닌 100mg/ℓ, pH 7.6Species medium: glucose 5%, peptone 0.5%, broth 0.5%, yeast extract 1%, sodium chloride 0.25%, adenine 100 mg / l, guanine 100 mg / l, pH 7.6

발효배지: 인산제1칼륨 1.5%, 인산제2칼륨 2.5%, 염화암모늄 1%, 황산마그네슘 1%, 염화칼슘 0.01%, 황산철 10mg/ℓ, 황산망간 10mg/ℓ, 황산아연 10mg/ℓ, 옥수수침지여액 20%, 바이오틴 30㎍/ℓ, 티아민염산 5mg/ℓ, 아데닌 100mg/ℓ, 구아닌 100mg/ℓ, 포도당 및 당밀을 혼합하여 환원당으로 6%(포도당 5.6%, 당밀 0.4%)되게 첨가하여 사용하였다.Fermentation medium: 1.5% potassium phosphate, 2.5% potassium diphosphate, 1% ammonium chloride, 1% magnesium sulfate, 0.01% calcium chloride, 10mg / l iron sulfate, 10mg / l manganese sulfate, 10mg / l zinc sulfate, corn 20% dipping filtrate, biotin 30㎍ / ℓ, thiamine hydrochloride 5mg / ℓ, adenine 100mg / ℓ, guanine 100mg / ℓ, glucose and molasses are mixed and added to reducing sugar 6% (glucose 5.6%, molasses 0.4%) It was.

발효방법: 상기 종배지 3㎖를 지름 18mm 시험관에 분주하고 상법에 따라 가압 살균한후 사용 균주를 접종하고 30℃에서 24시간 진탕배양하여 종배양액으로 사용하였다. 발효배지 40㎖를 500㎖ 진탕용 삼각플라스크에 분주하고 120℃에서 10 분간 가압 살균하여 종배양액 3㎖를 식균한후 5일간 배양하였다. 회전수는 분당 200회, 온도 30℃, pH 7.0으로 조절하였다. 배지내 5'-이노신산의 축적량은 7.2g/lℓ이었다. 이때 포도당 분석기를 이용하여 잔류 포도당을 측정한 결과, 포도당이 1.6% 남은 상태로 포도당을 100% 분해하지 못하였음을 알 수 있었다.Fermentation method: 3 ml of the seed medium was dispensed into a 18 mm diameter test tube, autoclaved and sterilized according to a conventional method, followed by inoculation of the strain used, followed by shaking culture at 30 ° C. for 24 hours. 40 ml of the fermentation broth was dispensed into a 500 ml shake flask, sterilized under pressure at 120 ° C. for 10 minutes, and 3 ml of the culture medium was incubated for 5 days. Rotation speed was adjusted to 200 times per minute, temperature 30 ℃, pH 7.0. The accumulated amount of 5'-inosinic acid in the medium was 7.2 g / lL. As a result of measuring the residual glucose using the glucose analyzer, it could be seen that the glucose could not be decomposed 100% with 1.6% remaining glucose.

비교예 2Comparative Example 2

사용 균주: KFCC-10814Strain used: KFCC-10814

종배지: 포도당 5%, 펩톤 0.5%, 육즙 0.5%, 효모엑기스 1%, 염화나트륨 0.25%, 아데닌 100mg/ℓ, 구아닌 100mg/ℓ, pH 7.6Species medium: glucose 5%, peptone 0.5%, broth 0.5%, yeast extract 1%, sodium chloride 0.25%, adenine 100 mg / l, guanine 100 mg / l, pH 7.6

발효배지: 인산제1칼륨 1.5%, 인산제2칼륨 2.5%, 염화암모늄 1%, 황산마그네슘 1%, 염화칼슘 0.01%, 황산철 10mg/ℓ, 황산망간 10mg/ℓ, 황산아연 10mg/ℓ, 옥수수침지여액 20%, 바이오틴 30㎍/ℓ, 티아민염산 5mg/ℓ, 아데닌 100mg/ℓ, 구아닌 100mg/ℓ, 과당, 포도당 및 당밀을 혼합하여 환원당으로 6%(과당 2.8%, 포도당 2.8%, 당밀 0.4%)되게 첨가하여 사용하였다.Fermentation medium: 1.5% potassium phosphate, 2.5% potassium diphosphate, 1% ammonium chloride, 1% magnesium sulfate, 0.01% calcium chloride, 10mg / l iron sulfate, 10mg / l manganese sulfate, 10mg / l zinc sulfate, corn Dipping Filtrate 20%, Biotin 30㎍ / ℓ, Thiamine Hydrochloride 5mg / ℓ, Adenine 100mg / ℓ, Guanine 100mg / ℓ, Fructose, Glucose and Molasses are mixed, 6% as reducing sugar (Fructose 2.8%, Glucose 2.8%, Molasses 0.4 %) Was used.

발효방법: 상기 종배지 3㎖를 지름 18mm 시험관에 분주하고 상법에 따라 가압 살균한후 사용 균주를 접종하고 30℃에서 24시간 진탕배양하여 종배양액으로 사용하였다. 발효배지 40㎖를 500㎖ 진탕용 삼각플라스크에 분주하고 120℃에서 10분간 가압 살균하여 종배양액 3㎖를 식균한후 5일간 배양하였다. 회전수는 분당 200회, 온도 30℃, pH 7.0으로 조절하였다. 배지내 5'-이노신산의 축적량은 15.2g/ℓ이었다.Fermentation method: 3 ml of the seed medium was dispensed into a 18 mm diameter test tube, autoclaved and sterilized according to a conventional method, followed by inoculation of the strain used, followed by shaking culture at 30 ° C. for 24 hours. 40 ml of the fermentation broth was dispensed into a 500 ml shake flask, and sterilized under pressure at 120 ° C. for 10 minutes to incubate 3 ml of the culture medium and incubated for 5 days. Rotation speed was adjusted to 200 times per minute, temperature 30 ℃, pH 7.0. The accumulation amount of 5'-inosinic acid in the medium was 15.2 g / l.

실시예 3Example 3

사용균주: MP377(KFCC-11141)Use strain: MP377 (KFCC-11141)

종배지: 실시예 1과 동일Species Medium: same as Example 1

발효배지: 인산 2%, 수산화칼륨 2%, 황산마그네슘 1%, 염화칼슘 0.01%, 황산철 10mg/㎖, 황산망간 10mg/㎖, 황산아연 10mg/㎖, 옥수수침지여액 20%, 바이오틴 30㎍/㎖, 티아민염산염 5mg/ℓ, 아데닌 200mg/ℓ, 구아닌 100mg/ℓ, 포도당 및 당밀을 혼합하여 총환원당으로서 18%(포도당 16.8%, 당밀 1.2%)되게 첨가하여 사용하였다.Fermentation medium: Phosphoric acid 2%, potassium hydroxide 2%, magnesium sulfate 1%, calcium chloride 0.01%, iron sulfate 10mg / ml, manganese sulfate 10mg / ml, zinc sulfate 10mg / ml, corn steep filtrate 20%, biotin 30µg / ml , 5 mg / l thiamine hydrochloride, 200 mg / l adenine, 100 mg / l guanine, glucose and molasses were mixed and used to add 18% (glucose 16.8%, molasses 1.2%) as total reducing sugar.

발효방법: 상기 종배지 40㎖를 500㎖ 진탕배양용 삼각플라스크에 분주하고 상법에 따라 가압 살균한후 사용 균주를 접종하고 30℃에서 24시간 진탕배양하여 종배양액으로 사용하였다. 발효배지 1600㎖를 5ℓ 발효조에 사입하고 120℃에서 15분간 가압 살균하여 종배양액 200㎖를 식균한후 3∼4일간 배양하였다. 회전수 분당 900회, 온도 28∼34℃, pH 7.0으로 조절하였다. 또한, 발효시 당이 2%가 되었을때 1차, 2차 및 3차 추가당을 포도당 및 당밀을 혼합하여 최종 환원당으로 각각 8% 되도록 첨가하였다. 배지내 5'-이노신산의 축적량은 66.4g/ℓ이었다.Fermentation method: 40 ml of the seed medium was dispensed into a 500 ml shake culture Erlenmeyer flask and autoclaved according to the conventional method, followed by inoculation of the used strain and shaking culture at 30 ° C. for 24 hours to use as a seed culture solution. 1600 ml of fermentation broth was inserted into a 5 L fermenter, autoclaved at 120 ° C. for 15 minutes, and 200 ml of the culture medium was incubated for 3 to 4 days. The rotation speed was adjusted to 900 times per minute, at a temperature of 28 to 34 ° C. and pH 7.0. In addition, when the sugar became 2% at the time of fermentation, the primary, secondary and tertiary additional sugars were added to be 8% as the final reducing sugar by mixing glucose and molasses, respectively. The accumulation amount of 5'-inosinic acid in the medium was 66.4 g / l.

실시예 4Example 4

사용균주: MP377(KFCC-11141)Use strain: MP377 (KFCC-11141)

종배지: 실시예 1과 동일Species Medium: same as Example 1

발효배지: 인산 2%, 수산화칼륨 2%, 황산마그네슘 1%, 염화칼슘 0.01%, 황산철 10mg/㎖, 황산망간 10mg/㎖, 황산아연 10mg/㎖, 옥수수침지여액 20%, 바이오틴 30㎍/㎖, 티아민염산염 5mg/ℓ, 아데닌 200mg/ℓ, 구아닌 100mg/ℓ, 과당, 포도당 및 당밀을 혼합하여 총환원당으로 18%(과당 8.4%, 포도당 8.4%, 당밀 1.2%)되게 첨가하여 사용하였다.Fermentation medium: Phosphoric acid 2%, potassium hydroxide 2%, magnesium sulfate 1%, calcium chloride 0.01%, iron sulfate 10mg / ml, manganese sulfate 10mg / ml, zinc sulfate 10mg / ml, corn steep filtrate 20%, biotin 30µg / ml Thiamine hydrochloride 5mg / l, adenine 200mg / l, guanine 100mg / l, fructose, glucose and molasses were mixed and used to add 18% (8.4% fructose, 8.4% glucose, 1.2% molasses) as the total reducing sugar.

발효방법: 상기 종배지 40㎖를 500㎖ 진탕배양용 삼각플라스크에 분주하고 상법에 따라 가압 살균한후 사용 균주를 접종하고 30℃에서 24시간 진탕배양하여 종배양액으로 사용하였다. 발효배지 1600㎖를 5ℓ 발효조에 사입하고 120℃에서 15분간 가압 살균하여 종배양액 200㎖를 식균한후 3∼4일간 배양하였다. 회전수 분당 900회, 28∼34℃, pH 7.0으로 조절하였다. 또한, 발효시 당이 2%가 되었을 때 1차, 2차 및 3차 추가당을 포도당 및 당밀을 혼합하여 최종 환원당으로 각각 8% 되도록 첨가하였다. 배지내 5'-이노신산의 축적량은 58.8g/ℓ이었다.Fermentation method: 40 ml of the seed medium was dispensed into a 500 ml shake culture Erlenmeyer flask and autoclaved according to the conventional method, followed by inoculation of the used strain and shaking culture at 30 ° C. for 24 hours to use as a seed culture solution. 1600 ml of fermentation broth was inserted into a 5 L fermenter, autoclaved at 120 ° C. for 15 minutes, and 200 ml of the culture medium was incubated for 3 to 4 days. The rotation speed was adjusted to 900 times per minute, 28 to 34 ° C., pH 7.0. In addition, when the sugar became 2% during fermentation, the primary, secondary and tertiary additional sugars were added so that 8% of the final reducing sugars were mixed with glucose and molasses. The accumulated amount of 5'-inosinic acid in the medium was 58.8 g / l.

비교예 3Comparative Example 3

사용균주: KFCC-10814Use strain: KFCC-10814

종배지: 실시예 1과 동일Species Medium: same as Example 1

발효배지: 인산 2%, 수산화칼륨 2%, 황산마그네슘 1%, 염화칼슘 0.01%, 황산철 10mg/㎖, 황산망간 10mg/㎖, 황산아연 10mg/㎖, 옥수수침지여액 20%, 바이오틴 30㎍/㎖, 티아민염산염 5mg/ℓ, 아데닌 200mg/ℓ, 구아닌 100mg/ℓ, 포도당 및 당밀을 혼합하여 총환원당으로서 18%(포도당 16.8%, 당밀 1.2%)되게 첨가하여 사용하였다.Fermentation medium: Phosphoric acid 2%, potassium hydroxide 2%, magnesium sulfate 1%, calcium chloride 0.01%, iron sulfate 10mg / ml, manganese sulfate 10mg / ml, zinc sulfate 10mg / ml, corn steep filtrate 20%, biotin 30µg / ml , 5 mg / l thiamine hydrochloride, 200 mg / l adenine, 100 mg / l guanine, glucose and molasses were mixed and used to add 18% (glucose 16.8%, molasses 1.2%) as total reducing sugar.

발효방법: 상기 종배지 40㎖를 500㎖ 진탕배양용 삼각플라스크에 분주하고 상법에 따라 가압 살균한후 사용 균주를 접종하고 30℃에서 24시간 진탕배양하여 종배양액으로 사용하였다. 발효배지 1600㎖를 5ℓ 발효조에 사입하고 120℃에서 15분간 가압 살균하여 종배양액 200㎖를 식균한후 3∼4일간 배양하였다. 회전수 분당 900회, 온도 28∼34℃, pH 7.0으로 조절하였다. 또한, 발효시 당이 2%가 되었을때 1차, 2차 및 3차 추가당을 포도당 및 당밀을 혼합하여 최종 환원당으로 각각 8% 되도록 첨가하였다. 배지내 5'-이노신산의 축적량은 44.7g/ℓ이었다.Fermentation method: 40 ml of the seed medium was dispensed into a 500 ml shake culture Erlenmeyer flask and autoclaved according to the conventional method, followed by inoculation of the used strain and shaking culture at 30 ° C. for 24 hours to use as a seed culture solution. 1600 ml of fermentation broth was inserted into a 5 L fermenter, autoclaved at 120 ° C. for 15 minutes, and 200 ml of the culture medium was incubated for 3 to 4 days. The rotation speed was adjusted to 900 times per minute, at a temperature of 28 to 34 ° C. and pH 7.0. In addition, when the sugar became 2% at the time of fermentation, the primary, secondary and tertiary additional sugars were added to be 8% as the final reducing sugar by mixing glucose and molasses, respectively. The accumulation amount of 5'-inosinic acid in the medium was 44.7 g / l.

비교예 4Comparative Example 4

사용균주: KFCC-10814Use strain: KFCC-10814

종배지: 실시예 1과 동일Species Medium: same as Example 1

발효배지: 인산 2%, 수산화칼륨 2%, 황산마그네슘 1%, 염화칼슘 0.01%, 황산철 10mg/㎖, 황산망간 10mg/㎖, 황산아연 10mg/㎖, 옥수수침지여액 20%, 바이오틴 30㎍/㎖, 티아민염산염 5mg/ℓ, 아데닌 200mg/ℓ, 구아닌 100mg/ℓ, 과당, 포도당 및 당밀을 혼합하여 총환원당으로 18%(과당 8.4%, 포도당 8.4%, 당밀 1.2%)되게 첨가하여 사용하였다.Fermentation medium: Phosphoric acid 2%, potassium hydroxide 2%, magnesium sulfate 1%, calcium chloride 0.01%, iron sulfate 10mg / ml, manganese sulfate 10mg / ml, zinc sulfate 10mg / ml, corn steep filtrate 20%, biotin 30µg / ml Thiamine hydrochloride 5mg / l, adenine 200mg / l, guanine 100mg / l, fructose, glucose and molasses were mixed and used to add 18% (8.4% fructose, 8.4% glucose, 1.2% molasses) as the total reducing sugar.

발효방법: 상기 종배지 40㎖를 500㎖ 진탕배양용 삼각플라스크에 분주하고상법에 따라 가압 살균한후 사용 균주를 접종하고 30℃에서 24시간 진탕배양하여 종배양액으로 사용하였다. 발효배지 1600㎖를 5ℓ 발효조에 사입하고 120℃에서 15분간 가압 살균하여 종배양액 200㎖를 식균한후 3∼4일간 배양하였다. 회전수 분당 900회, 온도 28∼34℃, pH 7.0으로 조절하였다. 또한, 발효시 당이 2%가 되었을때 1차, 2차 및 3차 추가당을 포도당 및 당밀을 혼합하여 최종 환원당으로 각각 8% 되도록 첨가하였다. 배지내 5'-이노신산의 축적량은 58.4g/ℓ이었다.Fermentation method: 40 ml of the seed medium was dispensed into a 500 ml shake culture conical flask and autoclaved according to the conventional method, followed by inoculation of the used strain and shaking culture at 30 ° C. for 24 hours to use as a seed culture solution. 1600 ml of fermentation broth was inserted into a 5 L fermenter, autoclaved at 120 ° C. for 15 minutes, and 200 ml of the culture medium was incubated for 3 to 4 days. The rotation speed was adjusted to 900 times per minute, at a temperature of 28 to 34 ° C. and pH 7.0. In addition, when the sugar became 2% at the time of fermentation, the primary, secondary and tertiary additional sugars were added to be 8% as the final reducing sugar by mixing glucose and molasses, respectively. The accumulation amount of 5'-inosinic acid in the medium was 58.4 g / l.

이상 설명한 바와 같이, 탄소원으로서 포도당과 과당의 1:1 혼합당을 이용하여 5'-이노신산을 고농도로 생산하는 코리네박테리움 암모니아게네스 KFCC-10814에 대해 6-머캅토퓨린 내성을 부여함으로써, 탄소원으로서 포도당만을 이용하여 5'-이노신산을 고농도로 생산하는 변이주를 손쉽게 획득할 수 있었다. 통상적인 발효에서 탄소원으로서 원당 가수분해물의 포도당과 과당의 1:1 혼합당에 비하여 포도당의 가격이 저렴하므로, 상기한 방법에 의해 획득한 변이주를 사용하여 보다 경제적인 방법으로 5'-이노신산을 생산할 수 있는 기반을 확립하였다.As described above, by imparting 6-mercaptopurine resistance to Corynebacterium ammonia genes KFCC-10814, which produces a high concentration of 5'-inosinic acid using a 1: 1 mixed sugar of glucose and fructose as a carbon source, Using only glucose as a carbon source, it was easy to obtain a mutant strain that produces a high concentration of 5'-inosinic acid. Since the price of glucose is lower than that of 1: 1 mixed sugar of glucose and fructose of raw sugar hydrolyzate as a carbon source in conventional fermentation, it is possible to produce 5'-inosinic acid in a more economical manner by using the mutants obtained by the above method. We have established a foundation for this.

본 발명에 따른 코리네박테리움 암모니아게네스 MP377은 탄소원으로서 포도당만을 사용하여 배양액내에 5'-이노신산을 고농도로 축적할 수 있으므로, 보다 경제적인 방법으로 5'-이노신산을 고농도·고수율로 제조할 수 있다.Corynebacterium ammonia genes MP377 according to the present invention can accumulate 5'-inosinic acid in a high concentration in the culture medium using only glucose as a carbon source, it is possible to produce 5'-inosinic acid at high concentration and high yield in a more economic way Can be.

Claims (4)

포도당을 자화하여 5'-이노신산을 생산하는 코리네박테리움 암모니아게네스(Corynebacterium ammoniagenes) MP377(KFCC-11141). Corynebacterium ammoniagenes MP377 (KFCC-11141), which magnetizes glucose to produce 5'-inosinic acid. 제 1 항에 있어서, 300㎍/㎖ 이상의 6-머캅토퓨린에 대해 내성을 갖는 코리네박테리움 암모니아게네스 MP377.The Corynebacterium ammonia genes MP377 according to claim 1, which is resistant to at least 300 µg / ml 6-mercaptopurine. 제 1 항 또는 제 2 항에 따른 미생물을 배양하여 그 배양물로부터 5'-이노신산을 제조하는 방법.A method for producing 5'-inosinic acid from the culture by culturing the microorganism according to claim 1 or 2. 제 3 항에 있어서, 탄소원으로서 포도당을 사용하는 방법.4. The method of claim 3, wherein glucose is used as the carbon source.
KR1020000013303A 2000-03-16 2000-03-16 5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same KR100330706B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020000013303A KR100330706B1 (en) 2000-03-16 2000-03-16 5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020000013303A KR100330706B1 (en) 2000-03-16 2000-03-16 5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same

Publications (2)

Publication Number Publication Date
KR20010089946A KR20010089946A (en) 2001-10-17
KR100330706B1 true KR100330706B1 (en) 2002-04-03

Family

ID=19655738

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020000013303A KR100330706B1 (en) 2000-03-16 2000-03-16 5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same

Country Status (1)

Country Link
KR (1) KR100330706B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000072445A (en) * 2000-09-04 2000-12-05 쓰루 슈수케 Manufacture method of Hypoxanthine.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000072445A (en) * 2000-09-04 2000-12-05 쓰루 슈수케 Manufacture method of Hypoxanthine.

Also Published As

Publication number Publication date
KR20010089946A (en) 2001-10-17

Similar Documents

Publication Publication Date Title
WO2017034343A1 (en) Microorganism having l-leucine productivity, and method for preparing l-leucine using same
CN100482782C (en) Microorganism of corynebacterium genus having resistance to kanamycin and enhanced L-lysine productivity and method of producing L-lysine using the same
AU2002323752B2 (en) Microorganism overproducing 5'-xanthylic acid
EP0092709A2 (en) Process for producing L-hystidine by fermentation and microorganisms therefor
KR100330706B1 (en) 5'-inosinic acid-producing microorganism and method for preparing 5'-inosinic acid using the same
KR100344017B1 (en) 5'-Xanthylic acid producing microorganism
WO2004050863A1 (en) Microorganism for producing riboflavin and method for producing riboflavin using the same
KR100446113B1 (en) Microorganism producing 5-inosinic acid and process for producing 5-inosinic acid using the same
RU2312137C2 (en) Strain corynebacterium ammoniagenes as producer of 5'-xanthylic acid and method for preparing 5'-xanthylic acid
RU2312140C2 (en) Strain corynebacterium ammoniagenes as producer of 5'-xanthylic acid and method for preparing 5'-xanthylic acid
KR100330705B1 (en) Inosine-producing microorganism and method for preparing inosine using the same
KR100588577B1 (en) Microorganism producing 5?-inosinic acid and production method of 5?-inosinic acid using the same
KR970010566B1 (en) Microorganism producing 5'-inosinic acid
KR100671081B1 (en) Microorganism producing inosine and process of preparing 5'-inosinic acid using same
WO2006059877A1 (en) Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same
KR100424847B1 (en) 5'-inosinic acid producing microorganism and process for production thereof
KR900003739B1 (en) 5'-inosinic acid producing microorganism
KR100338372B1 (en) 5'-Inosinic acid-producing microorganism
KR100424846B1 (en) 5'-inosinic acid producing microorganism and the process for production thereof
KR950005924B1 (en) Preparation method of 5'-guanylic acid by cultivation
KR100330712B1 (en) 5'-Inosinic acid-producing microorganism
KR100454888B1 (en) Microorganism producing 5'-inosinic acid
KR950005923B1 (en) Preparation method of 5'-inosine acid by cultivation
KR900003741B1 (en) 5'-inosinic acid producing microorganism
KR970002252B1 (en) MICROORGANISM PRODUCING 5óÑ-XANTHYL ACID

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080103

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee